Skip to main content
Log in

Steroid hormone receptors in human meningiomas, gliomas and brain metastases

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Progestin, estrogen, androgen, glucocorticoid as well as mineralocorticoid receptors (PR, ER, AR, GR and MR, respectively) were all evaluated with specific synthetic radioligands (biochemical assays) in 25 meningiomas, 9 gliomas and 4 brain metastases. In meningiomas the main steroid hormone receptors appeared to be the progestin receptor, present in 24/25 cases (mean level: 7 105 fmol/ gT) and the androgen receptor, present in 23/25 cases (mean level: 2 265 fmol/ gT). Progestin receptor levels were found to be significantly lower in meningiomas of the fibroblastic subtype whereas none of the steroid hormone receptors were detected in the anaplastic case. On the other hand, glucocorticoid receptor levels were related to the preoperative glucocorticoid therapy. In gliomas only estrogen receptors (2/9 cases) and especially androgen receptors (8/9 cases) were noticeable: the latter seemed to be related to the histological types and to the sex of patients. No receptors were found in any of the four studied metastases, including one from breast cancer. The biochemical characterization of the receptors as well as their relevance to tumor biology and to the physiology of the normal tissues where tumors arise, were discussed, and biochemical data were compared with those previously reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Donnell MS, Meyer GA, Donegan WL: Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50:499–502, 1979.

    Google Scholar 

  2. Poisson M, Magdelenat H, Foncin JF, Bleibel JM, Philippon J, Pertuiset B, Buce A: Récepteurs d'oestrogène et de progesterone dans les meningiomas. Etude de 22 cas. Rev Neurol (Paris) 136:193–203, 1980.

    Google Scholar 

  3. Johnson FE, Rosen PP, Menendez-Botet C, Schwartz MK, Ashikari R, Kinne DW: Estrogen receptor protein in visceral metastases from breast carcinoma. Am J Surg 142:252–254, 1981.

    Google Scholar 

  4. Kasantikul V, Brown WJ: Estrogen receptors in acoustic neurilemmoma. Surg Neurol 15:105–109, 1981.

    Google Scholar 

  5. Schnegg JF, Gomez F, Lemarchand-Beraud T, de Tribolet N: Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 15:415–418, 1981.

    Google Scholar 

  6. Martuza RL, Mac Laughin DT, Ojeman RG: Specific estradiol binding in schwannomas, meningiomas and neurofibromas. Neurosurgery 9:665–671, 1981.

    Google Scholar 

  7. Rengacharay SS, Tilzer LL: A study of dexamethasone receptor protein in human gliomas. J Surg Res 31:447–455, 1981.

    Google Scholar 

  8. Yu ZY, Wrange O, Boethius J, Hatam A, Granholm L, Gustafsson JA: A study of glucocorticoid receptors in intracranial tumors. J Neurosurg 55:757–760, 1981.

    Google Scholar 

  9. Yu ZY, Haglund B, Granholm L, Gustafsson JA: Estrogen and progestin receptors in intracranial meningiomas. J Steroid Biochem 16:451–456, 1982.

    Google Scholar 

  10. Tilzer LL, Plapp FV, Evans JP, Stone D, Award K: Steroid receptor proteins inhuman meningiomas. Cancer 49:633–636, 1982.

    Google Scholar 

  11. Magdelenat H, Pertuiset BF, Poisson M, Martin PM, Philippon J, Pertuiset B, Buge A: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir 64: 199–213, 1982.

    Google Scholar 

  12. Zulch KJ: Brain tumors. Their biology and pathology. Springer Publishing Company, New York, 1965, p 66.

    Google Scholar 

  13. Jellinger K: Glioblastoma multiforme. Morphology and biology. Acta Neurochir 42:5–32, 1978.

    Google Scholar 

  14. Dimant IN, Loktionov GM, Staev MM, Israilyan AA: Further study of induction of brain tumors in rats by Methylnitrosourea. Bull Exp Biol Med 69:566–568, 1970.

    Google Scholar 

  15. Hopewell JW: The hormone dependance of experimentally induced gliomas in the rat. Neuropathol Appl Neurobiol 1:141–148, 1975.

    Google Scholar 

  16. Zulch KJ: Histological classification of tumors of the central nervous system. WHO, Geneva, 1979.

    Google Scholar 

  17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 72:248–254, 1976.

    Google Scholar 

  18. Fiszer-Szafarz B, Szafarz D, Guevara de Murillo A: A general, fast and sensitive micromethod for DNA determination. Ana Biochem, 110:165–170, 1981.

    Google Scholar 

  19. Raynaud JP, Ojasoo T, Bouton MM, Philibert D: Receptor binding as a tool in the development of new bioactive steroids. In: Ariens EJ (ed) Drug design, vol VIII. Academic Press, New York, 1979, pp 169–214.

    Google Scholar 

  20. Ojasoo T, Raynaud JP: Unique steroid congeners for receptor studies. Cancer Res 38:4186–4198, 1978.

    Google Scholar 

  21. Zava DT, Landrum B, Horwitz KB, McGuire WL: Androgen receptor assay with (3H)methyltrienolone (R 1881) in the presence of progesterone receptors. Endocrinology 104: 1007–1012, 1979.

    Google Scholar 

  22. Asselin J, Melancon R, Gourdeau T, Labrie F, Bonne C, Raynaud JP: Specific binding of 3H-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). J Steroid Biochem 10:483–486, 1979.

    Google Scholar 

  23. Raynaud JP, Bouton MM, Martin PM: Human prostate hyperplasia and adenocarcinoma: steroid hormone receptor assays and therapy. In: Schröder FH, de Voogt HJ (eds) Steroid receptors, metabolism and prostatic cancer. Excerpta Medica, Amsterdam, 1980, pp 165–181.

    Google Scholar 

  24. Moguilewsky M, Raynaud JP: Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J Steroid Biochem 12:309–314, 1980.

    Google Scholar 

  25. Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672, 1949.

    Google Scholar 

  26. Moguilewsky M, Raynaud JP: Estrogen sensitive progestin binding sites in the female rat brain and pituitary. Brain Res 164:165–175,1979.

    Google Scholar 

  27. Westphal V: Steroid-Protein interactions. Springer-Verlag, Berlin, 1971, p 356.

    Google Scholar 

  28. Raynaud JP, Martin PM, Bouton MM, Ojasoo T: 11β-methoxy-17-ethynyl-1, 3, 5 (10)-estratriene-3, 17β-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues. Cancer Res 38:3044–3050, 1978.

    Google Scholar 

  29. McEwen BS, Wallach G, Magnus C: Corticocosterone binding to hippocampus: immediate and delayed influences of the absence of adrenal secretion. Brain Res 70:321–334, 1974.

    Google Scholar 

  30. McGuire WL: Steroid receptors in human breast cancer. Cancer Res 38:4289–4291, 1978.

    Google Scholar 

  31. Ramanath Rao B, Meyer JS, Glenn Fry C: Most cystosarcoma phyllodes and fibroradenomas have progesterone receptor but lack estrogen receptor. Cancer 47:2016–2021, 1981.

    Google Scholar 

  32. MacLusky NJ, McEwen BS: Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 274:276–278, 1978.

    Google Scholar 

  33. Blaustein JD, Wade GN: Progestin binding by brain and pituitary cell nuclei and female rat sexual behavior. Brain Res 140:360–367,1978.

    Google Scholar 

  34. Russel DS, Rubinstein LJ: Pathology of tumors of the nervous systeme. Edward Arnold, London, 1977, pp 65–100.

    Google Scholar 

  35. Nystrom SHM: A study on supratentorial meningiomas with special reference to gross and fine structure. Acta Pathol Microbiol Scand (Suppl) 176:1–90, 1965.

    Google Scholar 

  36. Escourolle R, Poirier J: Etude en microscopie électronique des tumeurs du systeme nerveux. Neuro chirurgie (suppl 1): 25–49,1971.

  37. Bailey OT: Histologic sequences in the meningioma with a consideration of the nature of hyperostosis cranii. Arch Pathol 30:42–69,1940.

    Google Scholar 

  38. Rascol M, Izard J, Jorda P, Rascol A: Etude ultrastructurale des méningiomas. Rev Med Toulouse 1:621–640, 1965.

    Google Scholar 

  39. Napolitano L, Kyle R, Fisher ER: Ultrastructure of meningiomas and the derivation and nature of their cellular components. Cancer 17:233–241, 1964.

    Google Scholar 

  40. Jellinger K, Slowik F: Histological subtypes and pronostic problemes in meningiomas. J Neurol 208:279–298, 1975.

    Google Scholar 

  41. Roth JG, Elvidge AR: Glioblastoma multiforme: A clinical survey. J Neurosurg 17:736–750, 1960.

    Google Scholar 

  42. Janisch W, Schreiber D: Experimental brain tumors. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 17/11. North-Holland, Amsterdam, 1974, pp 1–41.

    Google Scholar 

  43. Stewart J F, King RJB, Sexton SA, Millis RR, Ruben RDD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer 17:449–453, 1981.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Address for reprints: M. Poisson, Clinique Neurologique, Hôpital de la Salpetriere, 75651 Paris Cedex 13, France

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poisson, M., Pertuiset, B.F., Hauw, JJ. et al. Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neuro-Oncol 1, 179–189 (1983). https://doi.org/10.1007/BF00165601

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165601

Keywords

Navigation